Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MSP Recovery ( (MSPR) ) just unveiled an announcement.
On December 7, 2025, MSP Recovery, Inc. announced that the SEC concluded its investigation without recommending enforcement action against the company or its officers. The investigation, which began on August 11, 2022, focused on various aspects including a business combination transaction and financial statements. MSP Recovery fully cooperated with the SEC, and the conclusion allows the company to continue its operations without the burdens associated with the investigation.
The most recent analyst rating on (MSPR) stock is a Sell with a $0.30 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.
Spark’s Take on MSPR Stock
According to Spark, TipRanks’ AI Analyst, MSPR is a Underperform.
MSP Recovery’s overall stock score is heavily impacted by its dire financial performance and the looming threat of Nasdaq delisting. The technical analysis also indicates weak market momentum, and valuation metrics are unfavorable. These factors collectively contribute to a low overall stock score.
To see Spark’s full report on MSPR stock, click here.
More about MSP Recovery
Founded in 2014, MSP Recovery, Inc. is a leader in Medicare, Medicaid, commercial, and secondary payer reimbursement recovery. The company disrupts traditional healthcare reimbursement systems with data-driven solutions, providing innovative technologies and comprehensive solutions for industries such as healthcare and legal.
Average Trading Volume: 28,784,198
Technical Sentiment Signal: Sell
Current Market Cap: $4.56M
Learn more about MSPR stock on TipRanks’ Stock Analysis page.